People with sickle cell disease experience excruciating pain crises, tissue and organ damage, and shortened life expectancy. The lab of Stuart Orkin made crucial discoveries that, in the hands of CRISPR Therapeutics and Vertex Pharmaceuticals, became an FDA-approved gene therapy that is making a monumental impact on patients with sickle cell disease.
Related Posts
New AI Tool Predicts Long-Term Breast Cancer Recurrence Risk After Treatment
September 28, 2026
A revolutionary AI tool offers insights into late breast cancer recurrence risk, enhancing long-term patient care options for survivors.
Unlock Lean Muscle and Brain Power: Why Creatine is Worth Considering
September 28, 2026
Discover how creatine can enhance muscle mass and cognitive function, especially for adults 45+. Learn the benefits, dosage, and importance of exercise.
Is 16:8 Intermittent Fasting a Weight Loss Tool or a Health Cure?
September 21, 2026
Learn the benefits of 16:8 intermittent fasting for weight loss and its limitations for heart health. Discover what an 8-hour eating window entails.
AI Drug Reduces Aging Markers in Lung Disease Trial: What It Means for Healthspan
September 14, 2026
An AI-designed drug showed promise in lowering biological aging markers in lung disease. Discover what this could mean for health and longevity.